Abstract
The nuclear envelope has traditionally been looked at as a barrier separating the nucleus and cytoplasm and a complex organelle that disassembles and precisely reassembles during mitosis. However, the combination of cell biological discoveries localizing proteins to the nuclear envelope and human genetic investigations identifying disease-causing genes has show that the nuclear envelope must have tissue-selective functions beyond those general ones. Mutations in genes encoding proteins of the nuclear lamina, nuclear membranes, nuclear pore complexes and perinuclear space have been linked to a wide range of human diseases, sometimes called laminopathies or nuclear envelopathies, that often affect specific tissues and organ system. Genetic manipulations in model organisms and experiments on cultured cells have begun to decipher how mutations in genes encoding broadly expressed nuclear envelope proteins cause diseases. This research has even identified potential treatments for these rare diseases that impact on human health.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal AK, Fry’s JP, Auchus R et al (2003) Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12:1995–2001
Allgrove J, Clayden GS, Grant DB et al (1978) Familial glucocorticoid deficiency with achalasia of the cardia and deficient tear production. Lancet 1:1284–1286
Astejada MN, Goto K, Nagano A et al (2007) Emerinopathy and laminopathy clinical, pathological and molecular features of muscular dystrophy with nuclear envelopathy in Japan. Acta Myol 26:159–164
Attali R, Warwar N, Israel A et al (2009) Mutation of SYNE-1, encoding an essential component of the nuclear lamina, is responsible for autosomal recessive arthrogryposis. Hum Mol Genet 18:3462–3469
Barrowman J, Wiley PA, Hudon-Miller SE et al (2012) Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity. Hum Mol Genet 21:4084–4093
Basel-Vanagaite L, Muncher L, Straussberg R et al (2006) Mutated nup62 causes autosomal recessive infantile bilateral striatal necrosis. Ann Neurol 60:214–222
Bengtsson L, Otto H (2008) LUMA interacts with emerin and influences its distribution at the inner nuclear membrane. J Cell Sci 121:536–548
Ben Yaou R, Navarro C, Quijano-Roy S et al (2011) Type B mandibuloacral dysplasia with congenital myopathy due to homozygous ZMPSTE24 missense mutation. Eur J Hum Genet 19:647–654
Bergo MO, Gavino B, Ross J et al (2002) Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci U S A 99:13049–13054
Berk JM, Tifft KE, Wilson KL (2013) The nuclear envelope LEM-domain protein emerin. Nucleus 4:298–314
Bione S, Maestrini E, Rivella S et al (1994) Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 8:323–327
Boguslavsky RL, Stewart CL, Worman HJ (2006) Nuclear lamin A inhibits adipocyte differentiation: implications for Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 15:653–663
Bonne G, Di Barletta MR, Varnous S et al (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21:285–288
Borovik L, Modaff P, Waterham HR et al (2013) Pelger-huet anomaly and a mild skeletal phenotype secondary to mutations in LBR. Am J Med Genet A 161A:2066–2073
Bourgeois B, Gilquin B, Tellier-Lebègue C et al (2013) Inhibition of TGF-β signaling at the nuclear envelope: characterization of interactions between MAN1, Smad2 and Smad3, and PPM1A. Sci Signal 6:ra49
Brodsky GL, Muntoni F, Miocic S et al (2000) Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101:473–476
Brown RS, Zhao C, Chase AR et al (2014) The mechanism of Torsin ATPase activation. Proc Natl Acad Sci U S A 111:E4822–E4831
Cao H, Hegele RA (2000) Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 9:109–112
Cao K, Graziotto JJ, Blair CD et al (2011) Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med 3:89ra58
Capell BC, Erdos MR, Madigan JP et al (2005) Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 102:12879–12884
Capell BC, Olive M, Erdos MR et al (2008) A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc Natl Acad Sci U S A 105:15902–15907
Caux F, Dubosclard E, Lascols O et al (2003) A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 88:1006–1013
Chang W, Antoku S, Östlund C et al (2015a) Linker of nucleoskeleton and cytoskeleton (LINC) complex-mediated actin-dependent nuclear positioning orients centrosomes in migrating myoblasts. Nucleus 6:77–88
Chang W, Worman HJ, Gundersen GG (2015b) Accessorizing and anchoring the LINC complex for multifunctionality. J Cell Biol 208:11–22
Chen L, Lee L, Kudlow BA et al (2003) LMNA mutations in atypical Werner’s syndrome. Lancet 362:440–445
Choi JC, Muchir A, Wu W et al (2012) Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci Transl Med 4:144ra102
Clayton P, Fischer B, Mann A et al (2010) Mutations causing Greenberg dysplasia but not Pelger anomaly uncouple enzymatic from structural functions of a nuclear membrane protein. Nucleus 1:354–366
Coffinier C, Chang SY, Nobumori C et al (2010) Abnormal development of the cerebral cortex and cerebellum in the setting of lamin B2 deficiency. Proc Natl Acad Sci U S A 107:5076–5081
Coffinier C, Jung HJ, Nobumori C et al (2011) Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons. Mol Biol Cell 22:4683–4693
Cronshaw JM, Krutchinsky AN, Zhang W et al (2002) Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 158:915–927
Cronshaw JM, Matunis MJ (2003) The nuclear pore complex protein ALADIN is mislocalized in triple A syndrome. Proc Natl Acad Sci U S A 100:5823–5827
Csoka AB, Cao H, Sammak PJ et al (2004) Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet 41:304–308
Cutler DA, Sullivan T, Marcus-Samuels B et al (2002) Characterization of adiposity and metabolism in Lmna-deficient mice. Biochem Biophys Res Commun 291:522–527
Dauer WT, Worman HJ (2009) The nuclear envelope as a signaling node in development and disease. Dev Cell 17:626–638
DeBusk FL (1972) The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. J Pediatr 80:697–724
Decaudain A, Vantyghem MC, Guerci B et al (2007) New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab 92:4835–4844
Dechat T, Korbei B, Vaughan OA et al (2000) Lamina-associated polypeptide 2alpha binds intranuclear A-type lamins. J Cell Sci 113:3473–3484
De Sandre-Giovannoli A, Chaouch M, Kozlov S et al (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet 70:726–736
De Sandre-Giovannoli A, Bernard R, Cau P et al (2003) Lamin A truncation in Hutchinson-Gilford progeria. Science 300:2055
Dhe-Paganon S, Werner ED, Chi YI et al (2002) Structure of the globular tail of nuclear lamin. J Biol Chem 277:17381–17384
Dorboz I, Coutelier M, Bertrand AT et al (2014) Severe dystonia, cerebellar atrophy, and cardiomyopathy likely caused by a missense mutation in TOR1AIP1. Orphanet J Rare Dis 9:174
Dupré N, Gros-Louis F, Chrestian N (2007) Clinical and genetic study of autosomal recessive cerebellar ataxia type 1. Ann Neurol 62:93–98
Emery AE (1989) Emery-Dreifuss syndrome. J Med Genet 26:637–641
Eriksson M, Brown WT, Gordon LB et al (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423:293–298
Espada J, Varela I, Flores I et al (2008) Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J Cell Biol 181:27–35
Fatkin D, MacRae C, Sasaki T et al (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341:1715–1724
Foisner R, Gerace L (1993) Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation. Cell 73:1267–1279
Folker ES, Östlund C, Luxton GW et al (2011) Lamin A variants that cause striated muscle disease are defective in anchoring transmembrane actin-associated nuclear lines for nuclear movement. Proc Natl Acad Sci U S A 108:131–136
Fong LG, Frost D, Meta M et al (2006) A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 311:1621–1623
Fong LG, Ng JK, Meta M et al (2004) Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci U S A 101:18111–18116
Gabriel D, Roedl D, Gordon LB et al (2015) Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts. Aging Cell 14:78–91
Glynn MW, Glover TW (2005) Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet 14:2959–2969
Gonzalez-Alegre P, Paulson HL (2004) Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. J Neurosci 24:2593–2601
Goodchild RE, Dauer WT (2004) Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc Natl Acad Sci U S A 101:847–852
Goodchild RE, Dauer WT (2005) The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J Cell Biol 168:855–862
Goodchild RE, Kim CE, Dauer WT (2005) Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 48:923–932
Goldman RD, Shumaker DK, Erdos MR et al (2004) Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 101:8963–8968
Gordon LB, Harten IA, Patti ME et al (2005) Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome. J Pediatr 146:336–341
Gordon LB, Kleinman ME, Miller DT et al (2012) Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 109:16666–16671
Gros-Louis F, Dupré N, Dion P et al (2007) Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat Genet 39:80–85
Guilluy C, Osborne LD, Van Landeghem L et al (2014) Isolated nuclei adapt to force and reveal a mechanotransduction pathway in the nucleus. Nat Cell Biol 16:376–381
Gundersen GG, Worman HJ (2013) Nuclear positioning. Cell 152:1376–1389
Hellemans J, Preobrazhenska O, Willaert A et al (2004) Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nat Genet 36:1213–1218
Heng MY, Lin ST, Verret L et al (2013) Lamin B1 mediates cell-autonomous neuropathology in a leukodystrophy mouse model. J Clin Invest 123:2719–2729
Hernandez L, Roux KJ, Wong ES et al (2010) Functional coupling between the extracellular matrix and nuclear lamina by Wnt signaling in progeria. Dev Cell 19:413–425
Ho CY, Jaalouk DE, Vartiainen MK et al (2013) Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics. Nature 497:507–511
Hoffmann K, Dreger CK, Olins AL et al (2002) Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huët anomaly). Nat Genet 31:410–414
Holmer L, Pezhman A, Worman HJ (1998) The human lamin B receptor/sterol reductase multigene family. Genomics 54:469–476
Horn HF, Brownstein Z, Lenz DR et al (2013) The LINC complex is essential for hearing. J Clin Invest 123:740–750
Kayman-Kurekci G, Talim B, Korkusuz P et al (2014) Mutation in TOR1AIP1 encoding LAP1B in a form of muscular dystrophy: a novel gene related to nuclear envelopathies. Neuromuscul Disord 24:624–633
Kim CE, Perez A, Perkins G et al (2010) A molecular mechanism underlying the neural-specific defect in torsinA mutant mice. Proc Natl Acad Sci U S A 107:9861–9866
Korfali N, Wilkie GS, Swanson SK et al (2012) The nuclear envelope proteome differs notably between tissues. Nucleus 3:552–564
Krimm I, Östlund C, Gilquin B et al (2002) The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10:811–823
Lammerding J, Schulze PC, Takahashi T et al (2004) Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113:370–378
Li X, Roberti R, Blobel G (2015) Structure of an integral membrane sterol reductase from Methylomicrobium alcaliphilum. Nature 517:104–107
Liang WC, Mitsuhashi H, Keduka E et al (2011) TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy. Ann Neurol 69:1005–1013
Lin F, Blake DL, Callebaut I et al (2000) MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin. J Biol Chem 275:4840–4847
Lin F, Morrison JM, Wu W et al (2005) MAN1, an integral protein of the inner nuclear membrane, binds Smad2 and Smad3 and antagonizes transforming growth factor-beta signaling. Hum Mol Genet 14:437–445
Lin F, Worman HJ (1993) Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. Biol Chem 268:16321–16326
Lin ST, Zhang L, Lin X et al (2014) Nuclear envelope protein MAN1 regulates clock through BMAL1. Elife 3, e02981
Liu B, Ghosh S, Yang X et al (2012) Resveratrol rescues SIRT1-dependent adult stem cell decline and alleviates progeroid features in laminopathy-based progeria. Cell Metab 16:738–750
Liu B, Wang J, Chan KM et al (2005) Genomic instability in laminopathy-based premature aging. Nat Med 11:780–785
Liu Y, Rusinol A, Sinensky M et al (2006) DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A. J Cell Sci 119:4644–4649
Lombardi ML, Jaalouk DE, Shanahan CM et al (2011) The interaction between nesprins and sun proteins at the nuclear envelope is critical for force transmission between the nucleus and cytoskeleton. J Biol Chem 286:26743–26753
Lu JT, Muchir A, Nagy PL et al (2011) LMNA cardiomyopathy: cell biology and genetics meet clinical medicine. Dis Model Mech 4:562–568
Mallampalli MP, Huyer G, Bendale P et al (2005) Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A 102:14416–11421
Manilal S, Nguyen TM, Sewry CA et al (1996) The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet 5:801–808
Meinke P, Mattioli E, Haque F et al (2014) Muscular dystrophy-associated SUN1 and SUN2 variants disrupt nuclear-cytoskeletal connections and myonuclear organization. PLoS Genet 10, e1004605
Merideth MA, Gordon LB, Clauss S et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592–604
Mory PB, Crispim F, Freire MB et al (2012) Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations. Eur J Endocrinol 167:423–431
Moulson CL, Go G, Gardner JM et al (2005) Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J Invest Dermatol 125:913–919
Muchir A, Bonne G, van der Kooi AJ et al (2000) Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet 9:1453–1459
Muchir A, Pavlidis P, Decostre V et al (2007) Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest 117:1282–1293
Muchir A, Kim YJ, Reilly SA et al (2013) Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation. Skelet Muscle 3:17
Muchir A, Wu W, Choi JC et al (2012) Abnormal p38α mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation. Hum Mol Genet 21:4325–4333
Muchir A, Wu W, Worman HJ (2009) Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. Biochim Biophys Acta 1792:75–81
Nagano A, Koga R, Ogawa M et al (1996) Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet 12:254–259
Naismith TV, Heuser JE, Breakefield XO et al (2004) TorsinA in the nuclear envelope. Proc Natl Acad Sci U S A 101:7612–7617
Navarro CL, Cadiñanos J, De Sandre-Giovannoli A et al (2005) Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors. Hum Mol Genet 14:1503–1513
Neilson DE, Adams MD, Orr CM et al (2009) Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet 84:44–51
Novelli G, Muchir A, Sangiuolo F et al (2002) Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 71:426–431
Olive M, Harten I, Mitchell R et al (2010) Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arterioscler Thromb Vasc Biol 30:2301–2309
Ozelius LJ, Hewett JW, Page CE et al (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet 17:40–48
Padiath QS, Saigoh K, Schiffmann R et al (2006) Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet 38:1114–1123
Pan D, Estévez-Salmerón LD, Stroschein SL et al (2005) The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-β superfamily of cytokines. J Biol Chem 280:15992–16001
Pendás AM, Zhou Z, Cadiñanos J et al (2002) Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31:94–99
Puckelwartz MJ, Kessler EJ, Kim G et al (2010) Nesprin-1 mutations in human and murine cardiomyopathy. Mol Cell Cardiol 48:600–608
Raju GP, Dimova N, Klein PS et al (2003) SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1. J Biol Chem 278:428–437
Ramos FJ, Chen SC, Garelick MG et al (2012) Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med 4:144ra103
Roux KJ, Crisp ML, Liu Q et al (2009) Nesprin 4 is an outer nuclear membrane protein that can induce kinesin-mediated cell polarization. Proc Natl Acad Sci U S A 106:2194–2199
Scaffidi P, Misteli T (2008) Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol 10:452–459
Senior A, Gerace L (1988) Integral membrane proteins specific to the inner nuclear membrane and associated with the nuclear lamina. J Cell Biol 107:2029–2036
Shackleton S, Lloyd DJ, Jackson SN et al (2000) LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 24:153–156
Sinensky M, Fantle K, Trujillo M et al (1994) The processing pathway of prelamin A. J Cell Sci 107:61–67
Shin JY, Le Dour C, Sera F et al (2014) Depletion of lamina-associated polypeptide 1 from cardiomyocytes causes cardiac dysfunction in mice. Nucleus 5:260–459
Shin JY, Méndez-López I, Wang Y et al (2013) Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance. Dev Cell 26:591–603
Singh RR, Sedani S, Lim M et al (2015) RANBP2 mutation and acute necrotizing encephalopathy: 2 cases and a literature review of the expanding clinico-radiological phenotype. Eur J Paediatr Neurol 19:106–113
Sosa BA, Demircioglu FE, Chen JZ et al (2014) How lamina-associated polypeptide 1 (LAP1) activates Torsin. Elife 3, e03239
Speckman RA, Garg A, Du F et al (2000) Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. Am J Hum Genet 66:1192–1198
Stehbens WE, Wakefield SJ, Gilbert-Barness E et al (1999) Histological and ultrastructural features of atherosclerosis in progeria. Cardiovasc Pathol 8:29–39
Sullivan T, Escalante-Alcalde D, Bhatt H et al (1999) Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147:913–920
Taylor MR, Slavov D, Gajewski A et al (2005) Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat 26:566–574
Tazir M, Azzedine H, Assami S et al (2004) Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C. Brain 127:154–163
Toth JI, Yang SH, Qiao X et al (2005) Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc Natl Acad Sci U S A 102:12873–12878
Tullio-Pelet A, Salomon R, Hadj-Rabia S et al (2000) Mutant WD-repeat protein in triple-A syndrome. Nat Genet 26:332–335
Verstraeten VL, Ji JY, Cummings KS et al (2008) Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors. Aging Cell 7:383–393
Waterham HR, Koster J, Mooyer P et al (2003) Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene. Am J Hum Genet 72:1013–1017
Wojtanik KM, Edgemon K, Viswanadha S et al (2009) The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation. J Lipid Res 50:1068–1079
Worman HJ, Evans CD, Blobel G (1990) The lamin B receptor of the nuclear envelope inner membrane: a polytopic protein with eight potential transmembrane domains. J Cell Biol 111:1535–1542
Worman HJ, Fong LG, Muchir A et al (2009) Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 119:1825–1836
Worman HJ, Yuan J, Blobel G et al (1988) A lamin B receptor in the nuclear envelope. Proc Natl Acad Sci U S A 85:8531–8534
Wu W, Muchir A, Shan J et al (2011) Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene. Circulation 123:53–61
Yang SH, Andres DA, Spielmann HP et al (2008) Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated. J Clin Invest 118:3291–3300
Yang SH, Bergo MO, Toth JI et al (2005) Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci U S A 102:10291–10296
Yang SH, Chang SY, Ren S et al (2011) Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin. Hum Mol Genet 20:436–444
Yang SH, Meta M, Qiao X et al (2006) A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest 116:2115–2121
Ye Q, Worman HJ (1996) Interaction between an integral protein of the nuclear envelope inner membrane and human chromodomain proteins homologous to Drosophila HP1. J Biol Chem 271:14653–14656
Young SG, Yang SH, Davies BS et al (2013) Targeting protein prenylation in progeria. Sci Transl Med 5:171ps3
Zhang Q, Bethmann C, Worth NF (2007) Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet 16:2816–2833
Zhang X, Chen S, Yoo S et al (2008) Mutation in nuclear pore component NUP155 leads to atrial fibrillation and early sudden cardiac death. Cell 135:1017–1027
Zhang X, Yang H, Corydon MJ et al (1999) Localization of a human nucleoporin 155 gene (NUP155) to the 5p13 region and cloning of its cDNA. Genomics 57:144–151
Acknowledgements
The author is currently supported by grants from the United States National Institutes of Health (AR048997, NS059352, HD070713), the Muscular Dystrophy Association (MDA 294537) and Los Angeles Thoracic and Cardiovascular Foundation (CRV 2011-873R1).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Worman, H.J. (2016). Human Diseases Related to Nuclear Envelope Proteins. In: Bazett-Jones, D., Dellaire, G. (eds) The Functional Nucleus. Springer, Cham. https://doi.org/10.1007/978-3-319-38882-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-38882-3_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-38880-9
Online ISBN: 978-3-319-38882-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)